The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, Guy M., Knopman, David S., Chertkow, Howard, Hyman, Bradley T., Jack, Clifford R., Kawas, Claudia H., Klunk, William E., Koroshetz, Walter J. +10 more·2011·Alzheimer's & Dementia
DOI 10.1016/j.jalz.2011.03.005

Cited by (1,513)

Items 601–700 of 1,513

  1. Updates in Alzheimer's disease: from basic research to diagnosis and therapies
    Enjie Liu, Yao Zhang, Jian–Zhi Wang · 2024 · Translational Neurodegeneration
  2. Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease
    Fleisher, Adam S., Chen, Kewei, Liu, Xiaofen, Ayutyanont, Napatkamon, Roontiva, Auttawut, Thiyyagura, Pradeep, Protas, Hillary, Joshi, Abhinay D., Sabbagh, Marwan, Sadowsky, Carl H. et al. · 2013 · Neurobiology of Aging
  3. Mitochondria and Cell Bioenergetics: Increasingly Recognized Components and a Possible Etiologic Cause of Alzheimer's Disease
    Russell Howard Swerdlow · 2011 · Antioxidants and Redox Signaling
  4. Predicting MCI outcome with clinically available MRI and CSF biomarkers
    David S. Heister, James B. Brewer, Sebastian Magda, Kaj Blennow, Linda K. McEvoy, Alzheimer’s Disease Neuroimaging Initiative · 2011 · Neurology
  5. Alzheimer’s pathology targets distinct memory networks in the ageing brain
    Anne Maaß, David Berron, Theresa M. Harrison, Jenna N. Adams, Renaud La Joie, Suzanne L. Baker, Taylor J. Mellinger, Rachel K. Bell, Kaitlin N. Swinnerton, Ben A. Inglis et al. · 2019 · Brain
  6. Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease
    Parbo, Peter, Ismail, Rola, Hansen, Kim V., Amidi, Ali, Mårup, Frederik H., Gottrup, Hanne, Brændgaard, Hans, Eriksson, Bengt O., Eskildsen, Simon F., Lund, Torben E. et al. · 2017 · Brain
  7. Functional cognitive disorder: dementia’s blind spot
    Ball, Harriet A, McWhirter, Laura, Ballard, Clive, Bhome, Rohan, Blackburn, Daniel J, Edwards, Mark J, Fleming, Stephen M, Fox, Nick C, Howard, Robert, Huntley, Jonathan et al. · 2020 · Brain
  8. Association of diabetes with amnestic and nonamnestic mild cognitive impairment
    Rosebud O. Roberts, David S. Knopman, Yonas E. Geda, Ruth H. Cha, V. Shane Pankratz, Luke A. Baertlein, Bradley F. Boeve, Eric G. Tangalos, Robert J. Ivnik, Michelle M. Mielke et al. · 2013 · Alzheimer s & Dementia
  9. The paradox of syndromic diversity in Alzheimer disease
    Jason D. Warren, Phillip D. Fletcher, Hannah L. Golden · 2012 · Nature Reviews Neurology
  10. Aducanumab: Appropriate Use Recommendations Update
    Jeffrey L. Cummings, Gil Dan Rabinovici, Alireza Atri, Paul S. S. Aisen, Liana G. Apostolova, Suzanne B. Hendrix, Marwan Noel Sabbagh, Dennis J. Selkoe, Michael Walter Weiner, Stephen Salloway · 2022 · The Journal of Prevention of Alzheimer s Disease
  11. Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease
    Edmond Teng, Paul T. Manser, Karen Pickthorn, Flávia Brunstein, Mira Blendstrup, Sandra M. Sanabria Bohorquez, Kristin R. Wildsmith, Bali Toth, Michael J. Dolton, Vidya Ramakrishnan et al. · 2022 · JAMA Neurology
  12. Feeling, learning from and being aware of inner states: interoceptive dimensions in neurodegeneration and stroke
    García-Cordero, Indira, Sedeño, Lucas, de la Fuente, Laura, Slachevsky, Andrea, Forno, Gonzalo, Klein, Francisco, Lillo, Patricia, Ferrari, Jesica, Rodriguez, Clara, Bustin, Julian et al. · 2016 · Philosophical Transactions of the Royal Society B: Biological Sciences
  13. Early detection of Alzheimer's disease using PiB and FDG PET
    Ann D. Cohen, William Edward Klunk · 2014 · Neurobiology of Disease
  14. Prevalence, Distribution, and Impact of Mild Cognitive Impairment in Latin America, China, and India: A 10/66 Population-Based Study
    Ana Luisa Sosa, Emiliano Albanese, Blossom C. M. Stephan, Michael E. Dewey, Daisy M Acosta, Cleusa P. Ferri, Mariella Guerra, Yueqin Huang, K. S. Jacob, Ivonne Z. Jiménez‐Velázquez et al. · 2012 · PLoS Medicine
  15. Rapidly progressive Alzheimer’s disease features distinct structures of amyloid-β
    Mark L. Cohen, Chae Kim, Tracy Haldiman, Mohamed ElHag, Prachi Mehndiratta, Pichet Termsarasab, Frances M. Lissemore, Michelle Shea, Yvonne Cohen, Wei Chen et al. · 2015 · Brain
  16. Reactivated herpes simplex infection increases the risk of Alzheimer's disease
    Hugo Lövheim, Jonathan D. Gilthorpe, Rolf Adolfsson, Lars‐Göran Nilsson, Fredrik Elgh · 2014 · Alzheimer s & Dementia
  17. DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice
    Elsa Suberbielle, Biljana Djukic, Mark Evans, Daniel H. Kim, Praveen Taneja, Xin Wang, Mariel McKenzie Finucane, Joseph A. Knox, Kaitlyn Ho, Nino Devidze et al. · 2015 · Nature Communications
  18. Biomarker-based staging of Alzheimer disease: rationale and clinical applications
    Joseph Therriault, Suzanne E. Schindler, Gemma Salvadó, Tharick Ali Pascoal, Andréa Lessa Benedet, Nicholas James Ashton, Thomas K. Karikari, Liana G. Apostolova, Melissa Erin Murray, Inge M.W. Verberk et al. · 2024 · Nature Reviews Neurology
  19. The Health and Retirement Study Harmonized Cognitive Assessment Protocol Project: Study Design and Methods
    Kenneth M. Langa, Lindsay H. Ryan, Ryan J. McCammon, Richard Norman Jones, Jennifer Jaie Manly, Deborah A. Levine, Amanda J. Sonnega, Madeline R. Farron, David R. Weir · 2019 · Neuroepidemiology
  20. Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer's disease and their correlation with cognitive decline
    Taipa, Ricardo, das Neves, Sofia P., Sousa, Ana L., Fernandes, Joana, Pinto, Claudia, Correia, Ana P., Santos, Ernestina, Pinto, Pedro S., Carneiro, Paula, Costa, Patricio et al. · 2019 · Neurobiology of Aging
  21. The Prevalence of Mild Cognitive Impairment in China: A Systematic Review
    Jiang Xue, Jiarui Li, Jiaming Liang, Shulin Chen · 2018 · Aging and Disease
  22. Causes and Patterns of Dementia: An Update in the Era of Redefining Alzheimer's Disease
    Bryan David James, David Alan Bennett · 2019 · Annual Review of Public Health
  23. Cell type‐specific roles of APOE4 in Alzheimer disease
    Blumenfeld, Jessica, Yip, Oscar, Kim, Min Joo, Huang, Yadong · 2024 · Nature Reviews Neuroscience
  24. Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer’s disease during the COVID‐19 lockdown
    Lara, B., Carnes, A., Dakterzada, F., Benitez, I., Piñol‐Ripoll, G. · 2020 · European Journal of Neurology
  25. Microglial activation and tau burden predict cognitive decline in Alzheimer’s disease
    Malpetti, Maura, Kievit, Rogier A, Passamonti, Luca, Jones, P Simon, Tsvetanov, Kamen A, Rittman, Timothy, Mak, Elijah, Nicastro, Nicolas, Bevan-Jones, W Richard, Su, Li et al. · 2020 · Brain
  26. “Noncognitive” symptoms of early Alzheimer disease
    Mary Clare Masters, John C. Morris, Catherine M. Roe · 2015 · Neurology
  27. Network Dysfunction in Alzheimer's Disease: Refining the Disconnection Hypothesis
    Matthew R. Brier, Jewell Thomas, Beau M. Ances · 2014 · Brain Connectivity
  28. Early neurone loss in Alzheimer’s disease: cortical or subcortical?
    Thomas Arendt, Martina K. Brückner, Markus Morawski, Carsten Jäger, Hermann‐Josef Gertz · 2015 · Acta Neuropathologica Communications
  29. Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
    Jennifer Christina Howell, Kelly D. Watts, Monica W. Parker, Junjie Wu, Alexander L. Kollhoff, Thomas S. Wingo, Cornelya D. Dorbin, Deqiang Qiu, William T. Hu · 2017 · Alzheimer s Research & Therapy
  30. Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer’s Disease?
    Tamàs Fülöp, Jacek Maciej Witkowski, Karine Bourgade, Abdelouahed Khalil, Echarki Zerif, Anis Larbi, Katsuiku Hirokawa, Graham Pawelec, Christian Bocti, Guy Lacombe et al. · 2018 · Frontiers in Aging Neuroscience
  31. Alzheimer’s Disease in the Retina: Imaging Retinal Aβ Plaques for Early Diagnosis and Therapy Assessment
    Yosef Koronyo, Brenda C. Salumbides, Keith L. Black, Maya Koronyo‐Hamaoui · 2012 · Neurodegenerative Diseases
  32. Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease
    Bradley F. Boeve · 2013 · The Lancet Neurology
  33. The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
    José Luís Molinuevo, Kaj Blennow, Bruno Dubois, Sebastiaan Engelborghs, Piotr Lewczuk, Armand Perret‐Liaudet, Charlotte Elisabeth Teunissen, Lucilla Parnetti · 2014 · Alzheimer s & Dementia
  34. Deep ensemble learning for Alzheimer's disease classification
    Ning An, Huitong Ding, Jiaoyun Yang, Rhoda Au, Ting Fang Alvin Ang · 2020 · Journal of Biomedical Informatics
  35. Regional Aβ-tau interactions promote onset and acceleration of Alzheimer’s disease tau spreading
    Wha Jin Lee, Jesse A. Brown, Hye Ryun Kim, Renaud La Joie, Hanna Cho, Chul Hyoung Lyoo, Gil Dan Rabinovici, Joon‐Kyung Seong, William W. Seeley · 2022 · Neuron
  36. Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations
    Rajabli, Farid, Feliciano, Briseida E., Celis, Katrina, Hamilton-Nelson, Kara L., Whitehead, Patrice L., Adams, Larry D., Bussies, Parker L., Manrique, Clara P., Rodriguez, Alejandra, Rodriguez, Vanessa et al. · 2018 · PLOS Genetics
  37. Life Extension Factor Klotho Prevents Mortality and Enhances Cognition in hAPP Transgenic Mice
    Dena B. Dubal, Lei Zhu, Pascal E. Sanchez, Kurtresha Worden, Lauren Broestl, Erik C. B. Johnson, Kaitlyn Ho, Gui-Qiu Yu, Daniel Kim, Alexandre Bétourné et al. · 2015 · Journal of Neuroscience
  38. Recent Progress in Alzheimer’s Disease Research, Part 3: Diagnosis and Treatment
    Francis T. Hane, Morgan J. Robinson, Brenda Yasie Lee, Owen Bai, Zoya Leonenko, Mitchell S. Albert · 2017 · Journal of Alzheimer s Disease
  39. Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [ <sup>11</sup> C]UCB‐J
    Mecca, Adam P., O'Dell, Ryan S., Sharp, Emily S., Banks, Emmie R., Bartlett, Hugh H., Zhao, Wenzhen, Lipior, Sylwia, Diepenbrock, Nina G., Chen, Ming‐Kai, Naganawa, Mika et al. · 2022 · Alzheimer's &amp; Dementia
  40. Reporting standards for studies of diagnostic test accuracy in dementia
    Anna H Noel-Storr, Jenny M. McCleery, Edo Richard, Craig William Ritchie, Leon A Flicker, Sarah J. Cullum, Daniel H J Davis, Terence J. Quinn, Chris Hyde, Anne WS Rutjes et al. · 2014 · Neurology
  41. Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community
    Petersen, Ronald C., Wiste, Heather J., Weigand, Stephen D., Rocca, Walter A., Roberts, Rosebud O., Mielke, Michelle M., Lowe, Val J., Knopman, David S., Pankratz, Vernon S., Machulda, Mary M. et al. · 2016 · JAMA Neurology
  42. Higher Aortic Stiffness Is Related to Lower Cerebral Blood Flow and Preserved Cerebrovascular Reactivity in Older Adults
    Angela Lee Jefferson, Francis E. Cambronero, Dandan Liu, Elizabeth E. Moore, Jacquelyn E. Neal, James Greg Terry, Sangeeta Nair, Kimberly R. Pechman, Swati Rane, L. Taylor Davis et al. · 2018 · Circulation
  43. Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial
    William Joseph Herring, Paulette Ceesay, Ellen Snyder, Donald L. Bliwise, Kerry Budd, Jill Hutzelmann, Joanne Stevens, Christopher Lines, David Michelson · 2020 · Alzheimer s & Dementia
  44. Gut Microbiota in Alzheimer’s Disease, Depression, and Type 2 Diabetes Mellitus: The Role of Oxidative Stress
    Luca, Maria, Di Mauro, Maurizio, Di Mauro, Marco, Luca, Antonina · 2019 · Oxidative Medicine and Cellular Longevity
  45. The Quick Dementia Rating System (QDRS): A rapid dementia staging tool
    James E. Galvin · 2015 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  46. Subjective and objective cognitive decline at the pre-dementia stage of Alzheimer’s disease
    Frank Jessen · 2014 · European Archives of Psychiatry and Clinical Neuroscience
  47. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer’s Disease
    Emily C. Edmonds, Alzheimer’s Disease Neuroimaging Initiative, Lisa Delano‐Wood, Douglas R Galasko, David P. Salmon, Mark William Bondi · 2015 · Journal of Alzheimer s Disease
  48. Toward a redefinition of Parkinson's disease
    Matthew B. Stern, Anthony Edward Lang, Werner H Poewe · 2012 · Movement Disorders
  49. APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review
    Sheina Emrani, Hirra A. Arain, Cassandra A. DeMarshall, Tal Nuriel · 2020 · Alzheimer s Research & Therapy
  50. Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics
    Betty Marije Tijms, Johan Gobom, Lianne Maria Reus, Iris E. Jansen, Shengjun Hong, Valerija Dobričić, Fabian Kilpert, Mara ten Kate, Frederik Barkhof, Magda Tsolaki et al. · 2020 · Brain
  51. Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer’s disease using EEG technology
    Bin Jiao, Rihui Li, Hui Zhou, Kunqiang Qing, Hui Liu, Hefu Pan, Yanqin Lei, Wenjin Fu, Xiaoan Wang, Xuewen Xiao et al. · 2023 · Alzheimer s Research & Therapy
  52. Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control Analysis
    Chou, Richard C., Kane, Michael, Ghimire, Sanjay, Gautam, Shiva, Gui, Jiang · 2016 · CNS Drugs
  53. On the selection of non-invasive methods based on speech analysis oriented to automatic Alzheimer disease diagnosis
    López-de-Ipiña, Karmele, Alonso, Jesus-Bernardino, Travieso, Carlos, Solé-Casals, Jordi, Egiraun, Harkaitz, Faundez-Zanuy, Marcos, Ezeiza, Aitzol, Barroso, Nora, Ecay-Torres, Miriam, Martinez-Lage, Pablo et al. · 2013 · Sensors
  54. White Matter Hyperintensities and Cerebral Amyloidosis: Necessary and Sufficient for Clinical Expression of Alzheimer Disease?
    Provenzano, Frank A., Muraskin, Jordan, Tosto, Giuseppe, Narkhede, Atul, Wasserman, Ben T., Griffith, Erica Y., Guzman, Vanessa A., Meier, Irene B., Zimmerman, Molly E., Brickman, Adam M. et al. · 2013 · JAMA Neurology
  55. Impact of molecular imaging on the diagnostic process in a memory clinic
    Ossenkoppele, Rik, Prins, Niels D., Pijnenburg, Yolande A.L., Lemstra, Afina W., van der Flier, Wiesje M., Adriaanse, Sofie F., Windhorst, Albert D., Handels, Ron L.H., Wolfs, Claire A.G., Aalten, Pauline et al. · 2013 · Alzheimer's &amp; Dementia
  56. Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification
    Igor O. Korolev, Laura L. Symonds, Andrea Bozoki, Alzheimer’s Disease Neuroimaging Initiative · 2016 · PLoS ONE
  57. Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression
    C. Madeira, C. Vargas-Lopes, C. O. Brandão, T. Reis, J. Laks, R. Panizzutti, S. Ferreira · 2018 · Frontiers in Psychiatry
  58. Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial
    Howard, Robert, Zubko, Olga, Bradley, Rosie, Harper, Emma, Pank, Lynn, O’Brien, John, Fox, Chris, Tabet, Naji, Livingston, Gill, Bentham, Peter et al. · 2020 · JAMA Neurology
  59. Predicting clinical decline and conversion to Alzheimer’s disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays
    Kaj Blennow, Leslie M. J. Shaw, Erik Stomrud, Niklas Mattsson, Jon B. Toledo, Katharina Buck, Simone Wahl, Udo Eichenlaub, Valeria Lifke, Maryline Simon et al. · 2019 · Scientific Reports
  60. The Neuroprotective Potentiality of Flavonoids on Alzheimer’s Disease
    Antonella Calderaro, Giuseppe Tancredi Patanè, Ester Tellone, Davide Barreca, Silvana Ficarra, Francesco Misiti, Giuseppina Laganà · 2022 · International Journal of Molecular Sciences
  61. Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: consensus from the Canadian conference on diagnosis of dementia
    Howard Mark Chertkow, Howard Feldman, Claudia Jacova, Fadi Massoud · 2013 · Alzheimer s Research & Therapy
  62. Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales
    Harper, Lorna, Barkhof, Frederik, Fox, Nick C, Schott, Jonathan M · 2015 · Journal of Neurology, Neurosurgery &amp; Psychiatry
  63. Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-Amyloid Imaging in Aging and Dementia
    Christopher Cleon Rowe, Svetlana Pejoska, Rachel S. Mulligan, Gareth R. Jones, J. Gordon Chan, Samuel Svensson, Zsolt Cselényi, Colin Louis Masters, Victor L. Villemagne · 2013 · Journal of Nuclear Medicine
  64. Differential diagnosis of neurodegenerative diseases using structural MRI data
    Koikkalainen, Juha, Rhodius-Meester, Hanneke, Tolonen, Antti, Barkhof, Frederik, Tijms, Betty, Lemstra, Afina W., Tong, Tong, Guerrero, Ricardo, Schuh, Andreas, Ledig, Christian et al. · 2016 · NeuroImage: Clinical
  65. Predicting conversion from MCI to AD using resting-state fMRI, graph theoretical approach and SVM
    Seyed Hani Hojjati, Ata Ebrahimzadeh, Ali Khazaee, Abbas Babajani-feremi A · 2017 · Journal of Neuroscience Methods
  66. Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: A Two-year Follow-up Study
    Wei‐Ju Lee, Yi‐Chu Liao, Yen-Feng Wang, I-Feng Lin, Shuu‐Jiun Wang, Jong‐Ling Fuh · 2018 · Scientific Reports
  67. Cerebrovascular lesions induce transient  -amyloid deposition
    Garcia-Alloza, M., Gregory, J., Kuchibhotla, K. V., Fine, S., Wei, Y., Ayata, C., Frosch, M. P., Greenberg, S. M., Bacskai, B. J. · 2011 · Brain
  68. <sup>18</sup>F-FDG PET and Perfusion SPECT in the Diagnosis of Alzheimer and Lewy Body Dementias
    O’Brien, John T., Firbank, Michael J., Davison, Christopher, Barnett, Nicky, Bamford, Claire, Donaldson, Cam, Olsen, Kirsty, Herholz, Karl, Williams, David, Lloyd, Jim · 2014 · Journal of Nuclear Medicine
  69. Relevance of Magnetic Resonance Imaging for Early Detection and Diagnosis of Alzheimer Disease
    Stefan Johannes Teipel, Michel J. Grothe, Simone Lista, Nicola Toschi, Francesco Garaci, Harald Juergen Hampel · 2013 · Medical Clinics of North America
  70. The Role of Vascular Endothelial Growth Factor in Neurodegeneration and Cognitive Decline
    Timothy J. Hohman, Susan P. Bell, Angela Lee Jefferson · 2015 · JAMA Neurology
  71. Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
    Sherif Bayoumy, Inge M.W. Verberk, Ben den Dulk, Zulaiga Hussainali, Marissa Deborah Zwan, Wiesje M. van der Flier, Nicholas James Ashton, Henrik Zetterberg, Kaj Blennow, Jeroen Vanbrabant et al. · 2021 · Alzheimer s Research & Therapy
  72. Geographical variation in dementia: Systematic review with meta-analysis
    Russ, T. C., Batty, G. D., Hearnshaw, G. F., Fenton, C., Starr, J. M. · 2012 · International Journal of Epidemiology
  73. Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging
    van de Haar, Harm J., Jansen, Jacobus F.A., van Osch, Matthias J.P., van Buchem, Mark A., Muller, Majon, Wong, Sau May, Hofman, Paul A.M., Burgmans, Saartje, Verhey, Frans R.J., Backes, Walter H. · 2016 · Neurobiology of Aging
  74. Foreign language training as cognitive therapy for age-related cognitive decline: A hypothesis for future research
    Mark Antoniou, Geshri M. Gunasekera, Patrick C. M. Wong · 2013 · Neuroscience & Biobehavioral Reviews
  75. Functional Disability in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis
    Cutter A. Lindbergh, Rodney K. Dishman, Lloyd Stephen Miller · 2016 · Neuropsychology Review
  76. Understanding Alzheimer Disease at the Interface between Genetics and Transcriptomics
    Jan Verheijen, Kristel Sleegers · 2018 · Trends in Genetics
  77. Prevalence and risk of progression of preclinical Alzheimer’s disease stages: a systematic review and meta-analysis
    Lucilla Parnetti, Elena Chipi, Nicola Salvadori, Katia D’Andrea, Paolo Eusebi · 2019 · Alzheimer s Research & Therapy
  78. The incidence of mild cognitive impairment: A systematic review and data synthesis
    Cai Gillis, Fariba Mirzaei, Michele H. Potashman, M. Arfan Ikram, Nancy Nairi Maserejian · 2019 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  79. Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy
    Chouliaras, Leonidas, Thomas, Alan, Malpetti, Maura, Donaghy, Paul, Kane, Joseph, Mak, Elijah, Savulich, George, Prats-Sedano, Maria A, Heslegrave, Amanda J, Zetterberg, Henrik et al. · 2022 · Journal of Neurology, Neurosurgery &amp; Psychiatry
  80. Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease
    Victor L. Villemagne, Rachel S. Mulligan, Svetlana Pejoska, Kevin T Ong, Gareth R. Jones, Graeme Joseph O'Keefe, J. Gordon Chan, Kenneth Young, Henri Tochon‐Danguy, Colin Louis Masters et al. · 2012 · European Journal of Nuclear Medicine and Molecular Imaging
  81. The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment
    Natalie Sachs‐Ericsson, Dan German Blazer · 2014 · Aging & Mental Health
  82. Rey's Auditory Verbal Learning Test scores can be predicted from whole brain MRI in Alzheimer's disease
    Elaheh Moradi, Ilona Tuulia Hallikainen, Tuomo Hänninen, Jussi Tohka · 2016 · NeuroImage Clinical
  83. Mitochondrial genes are altered in blood early in Alzheimer's disease
    Lunnon, Katie, Keohane, Aoife, Pidsley, Ruth, Newhouse, Stephen, Riddoch-Contreras, Joanna, Thubron, Elisabeth B., Devall, Matthew, Soininen, Hikka, Kłoszewska, Iwona, Mecocci, Patrizia et al. · 2017 · Neurobiology of Aging
  84. Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias
    Eleanor King, John Tiernan O'Brien, Paul C. Donaghy, Christopher M. Morris, Nicola A. Barnett, Kirsty Olsen, Carmen M. Martin-Ruiz, John‐Paul Taylor, Alan J. Thomas · 2017 · Journal of Neurology Neurosurgery & Psychiatry
  85. EGCG Nanoparticles Attenuate Aluminum Chloride Induced Neurobehavioral Deficits, Beta Amyloid and Tau Pathology in a Rat Model of Alzheimer’s Disease
    Neha Singh, Vaishali Bhardwaj, Chandrika Ravi, N. Ramesh, A. Mandal, Z. Khan · 2018 · Frontiers in Aging Neuroscience
  86. Amyloid blood biomarker detects Alzheimer's disease
    Nabers, Andreas, Perna, Laura, Lange, Julia, Mons, Ute, Schartner, Jonas, Güldenhaupt, Jörn, Saum, Kai‐Uwe, Janelidze, Shorena, Holleczek, Bernd, Rujescu, Dan et al. · 2018 · EMBO Molecular Medicine
  87. Coenzyme Q10 Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases
    Gutierrez-Mariscal, Francisco Miguel, Arenas-de Larriva, Antonio Pablo, Limia-Perez, Laura, Romero-Cabrera, Juan Luis, Yubero-Serrano, Elena Maria, López-Miranda, Jose · 2020 · International Journal of Molecular Sciences
  88. Amyloid-β 42/40 Cerebrospinal Fluid Concentration Ratio in the Diagnostics of Alzheimer's Disease: Validation of Two Novel Assays
    Piotr Lewczuk, Natalia Lelental, Philipp Spitzer, Juan Manuel Maler, Johannes Kornhuber · 2014 · Journal of Alzheimer s Disease
  89. Lost in spatial translation – A novel tool to objectively assess spatial disorientation in Alzheimer's disease and frontotemporal dementia
    Sicong Tu, Stephanie Wong, John R. Hodges, Muireann Irish, Olivier Piguet, Michael Hornberger · 2015 · Cortex
  90. Early diagnosis of Alzheimer’s disease using machine learning: a multi-diagnostic, generalizable approach
    Vasco Sá Diogo, Hugo Alexandre Ferreira, Diana Pinto Prata, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Alzheimer s Research & Therapy
  91. Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis
    Che‐Sheng Chu, Ping‐Tao Tseng, Brendon Stubbs, Tien‐Yu Chen, Chia-Hung Tang, Dian‐Jeng Li, Wei‐Cheng Yang, Yen‐Wen Chen, Ching-Kuan Wu, Nicola Veronese et al. · 2018 · Scientific Reports
  92. Multimodal analysis of functional and structural disconnection in A lzheimer's disease using multiple kernel SVM
    Martin Dyrba, Michel J. Grothe, Thomas Kirste, Stefan Johannes Teipel · 2015 · Human Brain Mapping
  93. MIRIAD—Public release of a multiple time point Alzheimer's MR imaging dataset
    Ian B. Malone, David M. Cash, Gerard R. Ridgway, David G. MacManus, Sebastien Ourselin A, Nick C. Fox, Jonathan M. Schott · 2012 · NeuroImage
  94. Understanding the Amyloid Hypothesis in Alzheimer’s Disease
    Giulia Paroni, Paola Bisceglia, Davide Seripa · 2019 · Journal of Alzheimer s Disease
  95. ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease
    Novak, Petr, Kovacech, Branislav, Katina, Stanislav, Schmidt, Reinhold, Scheltens, Philip, Kontsekova, Eva, Ropele, Stefan, Fialova, Lubica, Kramberger, Milica, Paulenka-Ivanovova, Natalia et al. · 2021 · Nature Aging
  96. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases
    Dupont, Anne-Claire, Largeau, Bérenger, Santiago Ribeiro, Maria, Guilloteau, Denis, Tronel, Claire, Arlicot, Nicolas · 2017 · International Journal of Molecular Sciences
  97. Sex and gender differences in the causes of dementia: A narrative review
    Rocca, Walter A., Mielke, Michelle M., Vemuri, Prashanthi, Miller, Virginia M. · 2014 · Maturitas
  98. Heterogeneity in Alzheimer’s Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials
    Duara, Ranjan, Barker, Warren · 2022 · Neurotherapeutics
  99. Different patterns of gray matter atrophy in early- and late-onset Alzheimer’s disease
    Christiane Möller, Hugo Vrenken, Lize Corrine Jiskoot, Adriaan Versteeg, Frederik Barkhof, Philip Scheltens, Wiesje M. van der Flier · 2013 · Neurobiology of Aging
  100. A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease
    Nordberg, Agneta, Carter, Stephen F., Rinne, Juha, Drzezga, Alexander, Brooks, David J., Vandenberghe, Rik, Perani, Daniela, Forsberg, Anton, Långström, Bengt, Scheinin, Noora et al. · 2013 · European Journal of Nuclear Medicine and Molecular Imaging